Literature DB >> 861558

Sedation in liver disease.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861558      PMCID: PMC1607107     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Morphine tolerance in hepatic cirrhosis.

Authors:  J LAIDLAW; A E READ; S SHERLOCK
Journal:  Gastroenterology       Date:  1961-03       Impact factor: 22.682

2.  Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.

Authors:  A J Levi; S Sherlock; D Walker
Journal:  Lancet       Date:  1968-06-15       Impact factor: 79.321

3.  Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.

Authors:  J D Maxwell; M Carrella; J D Parkes; R Williams; G P Mould; S H Curry
Journal:  Clin Sci       Date:  1972-08       Impact factor: 6.124

4.  Blood level distribution patterns of diazepam and its major metabolite in man.

Authors:  J A De Silva; B A Koechlin; G Bader
Journal:  J Pharm Sci       Date:  1966-07       Impact factor: 3.534

5.  Intravenous administration of diazepam in patients with chronic liver disease.

Authors:  R A Branch; M H Morgan; J James; A E Read
Journal:  Gut       Date:  1976-12       Impact factor: 23.059

6.  Antidepressants and liver disease.

Authors:  M H Morgan; A E Read
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

7.  Metabolism of amylobarbitone in patients with chronic liver disease.

Authors:  G E Mawer; N E Miller; L A Turnberg
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

8.  Effects of chlorpromazine in patients with hepatic disease.

Authors:  A E Read; J Laidlaw; C F McCarthy
Journal:  Br Med J       Date:  1969-08-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.